Exhibit 99.1

BECTON DICKINSON AND COMPANY
CONDENSED CONSOLIDATED INCOME STATEMENTS
(Unaudited; Amounts in millions, except share and per share data)
Fiscal Year 2022Fiscal Year 2021Fiscal Year 2020Fiscal Year 2019
Three Months Ended December 31, 2021Three Months Ended December 31, 2020Three Months Ended March 31, 2021Three Months Ended June 30, 2021Three Months Ended September 30, 2021Twelve Months Ended September 30, 2021Twelve Months Ended September 30, 2020Twelve Months Ended September 30, 2019
REVENUES$4,718 $5,041 $4,634 $4,607 $4,849 $19,131 $16,074 $16,218 
Cost of products sold2,498 2,505 2,584 2,649 2,763 10,500 9,276 8,720 
Selling and administrative expense1,185 1,119 1,115 1,200 1,285 4,719 4,185 4,185 
Research and development expense314 278 304 330 368 1,279 1,039 1,004 
Acquisitions and other restructurings34 50 47 24 58 179 299 480 
Other operating (income) expense, net(4)— 296 (88)(5)203 363 654 
TOTAL OPERATING COSTS AND EXPENSES4,027 3,953 4,345 4,114 4,469 16,881 15,161 15,043 
OPERATING INCOME692 1,088 289 492 380 2,250 912 1,175 
Interest expense(98)(118)(124)(115)(111)(469)(528)(639)
Interest income2 2 2 2 2 9 7 12 
Other income (expense), net4 33 (10)(1)(120)(99)23 43 
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES600 1,005 158 378 151 1,692 414 591 
Income tax provision (benefit)32 135 (15)(28)(4)88 62 (141)
NET INCOME FROM CONTINUING OPERATIONS568 870 173 407 154 1,604 352 733 
Income from discontinued operations, net of tax109 133 127 118 110 488 522 500 
NET INCOME677 1,003 299 525 265 2,092 874 1,233 
Preferred stock dividends(23)(23)(23)(23)(23)(90)(107)(152)
NET INCOME APPLICABLE TO COMMON SHAREHOLDERS$655 $981 $277 $502 $242 $2,002 $767 $1,082 
BASIC EARNINGS PER SHARE
Income from Continuing Operations$1.92 $2.92 $0.52 $1.33 $0.46 $5.23 $0.88 $2.15 
Income from Discontinued Operations0.38 0.46 0.43 0.41 0.39 1.69 1.87 1.85 
Basic Earnings per Share$2.30 $3.38 $0.95 $1.73 $0.85 $6.92 $2.75 $4.01 
DILUTED EARNINGS PER SHARE
Income from Continuing Operations$1.90 $2.89 $0.51 $1.32 $0.46 $5.18 $0.87 $2.11 
Income from Discontinued Operations0.38 0.45 0.43 0.40 0.38 1.67 1.85 1.82 
Diluted Earnings per Share$2.28 $3.35 $0.94 $1.72 $0.84 $6.85 $2.71 $3.94 
AVERAGE SHARES OUTSTANDING (in thousands)
     Basic284,685290,590291,095289,522285,985289,288278,971269,943
     Diluted286,723293,112293,547291,897288,598292,089282,402274,775
Page 1

BECTON DICKINSON AND COMPANY
SUPPLEMENTAL INFORMATION
RECONCILIATION OF REPORTED RESULTS TO ADJUSTED RESULTS
(Unaudited; Amounts in millions, except per share data)
Three Months Ended December 31, 2021
Reported (GAAP)Purchase accounting adjustments (A)Integration costs (B)Restructuring costs (B)Transaction gain/loss, product and other litigation-related matters (C)European regulatory initiative-related costs (D)Investment gains/losses and asset impairments (E)Income tax benefit of special itemsAdjusted (Non-GAAP)
See Footnotes on Page 10
REVENUES$4,718 $— $— $— $— $— $— $— $4,718 
Gross margin2,221 358 — — — 10 — — 2,588 
Selling and administrative expense1,185 (7)— — — (1)— — 1,177 
Research and development expense314 — — — — (21)— — 293 
OPERATING INCOME692 365 17 17 — 31 — — 1,122 
Net interest expense(96)(1)— — — — — — (97)
Other income (expense), net4 — — — 5 — 17 — 26 
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES600 364 17 17 5 31 17 — 1,050 
Income tax provision32 — — — — — — 86 118 
NET INCOME FROM CONTINUING OPERATIONS$568 $364 $17 $17 $5 $31 $17 $(86)$933 
DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS$1.90 $1.27 $0.06 $0.06 $0.02 $0.11 $0.06 $(0.30)$3.17 

Page 2

BECTON DICKINSON AND COMPANY
SUPPLEMENTAL INFORMATION
RECONCILIATION OF REPORTED RESULTS TO ADJUSTED RESULTS
(Unaudited; Amounts in millions, except per share data)
Twelve Months Ended September 30, 2021
Reported (GAAP)Purchase accounting adjustments (A)Integration costs (B)Restructuring costs (B)Transaction gain/loss, product and other litigation-related matters (C)European regulatory initiative-related costs (D)Investment gains/losses and asset impairments (E)Impacts of debt extinguishment (F)Income tax benefit of special itemsAdjusted
(Non-GAAP)
See Footnotes on Page 10
REVENUES$19,131 $— $— $— $— $— $— $— $— $19,131 
Gross margin8,630 1,398 — — 63 41 — — — 10,132 
Selling and administrative expense4,719 (11)— — — (1)— — — 4,707 
Research and development expense1,279 (7)— — — (92)— — — 1,181 
OPERATING INCOME2,250 1,416 135 44 266 134 — — — 4,244 
Net interest expense(460)(7)— — — — — 6 — (460)
Other (expense) income, net(99)(5)— — 6 — (46)178 — 36 
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES1,692 1,405 135 44 272 134 (46)185 — 3,820 
Income tax provision88 — — — — — — — 348 435 
NET INCOME FROM CONTINUING OPERATIONS$1,604 $1,405 $135 $44 $272 $134 $(46)$185 $(348)$3,384 
DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS$5.18 $4.81 $0.46 $0.15 $0.93 $0.46 $(0.16)$0.63 $(1.19)$11.28 

Page 3

BECTON DICKINSON AND COMPANY
SUPPLEMENTAL INFORMATION
RECONCILIATION OF REPORTED RESULTS TO ADJUSTED RESULTS
(Unaudited; Amounts in millions, except per share data)
Three Months Ended December 31, 2020
Reported (GAAP)Purchase accounting adjustments (A)Integration costs (B)Restructuring costs (B)Transaction gain/loss, product and other litigation-related matters (C)European regulatory initiative-related costs (D)Impacts of debt extinguishment (F)Dilutive impact (H)Income tax benefit of special itemsAdjusted
(Non-GAAP)
See Footnotes on Page 10
REVENUES$5,041 $— $— $— $— $— $— $— $— $5,041 
Gross margin2,536 347 — — 8 9 — — — 2,899 
Selling and administrative expense1,119 (2)— — — — — — — 1,117 
Research and development expense278 (5)— — — (18)— — — 255 
OPERATING INCOME1,088 355 33 17 8 26 — — — 1,527 
Net interest expense(116)(2)— — — — — — — (118)
Other income (expense), net33 — — — (12)— 10 — — 31 
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES1,005 352 33 17 (5)26 11 — — 1,440 
Income tax provision135 — — — — — — — 79 213 
NET INCOME FROM CONTINUING OPERATIONS$870 $352 $33 $17 $(5)$26 $11 $— $(79)$1,227 
DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS$2.89 $1.20 $0.11 $0.06 $(0.02)$0.09 $0.04 $(0.01)$(0.27)$4.10 

Page 4

BECTON DICKINSON AND COMPANY
SUPPLEMENTAL INFORMATION
RECONCILIATION OF REPORTED RESULTS TO ADJUSTED RESULTS
(Unaudited; Amounts in millions, except per share data)
Three Months Ended March 31, 2021
Reported (GAAP)Purchase accounting adjustments (A)Integration costs (B)Restructuring costs (B)Transaction gain/loss, product and other litigation-related matters (C)European regulatory initiative-related costs (D)Impacts of debt extinguishment (F)Income tax benefit of special itemsAdjusted
(Non-GAAP)
See Footnotes on Page 10
REVENUES$4,634 $— $— $— $— $— $— $— $4,634 
Gross margin2,050 348 — — 37 11 — — 2,446 
Selling and administrative expense1,115 (1)— — — — — — 1,113 
Research and development expense304 — — — — (21)— — 282 
OPERATING INCOME289 349 33 14 333 32 — — 1,050 
Net interest expense(122)(1)— — — — 4 — (119)
Other (expense) income, net(10)— — — — — 15 — 6 
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES158 348 33 14 333 32 20 — 937 
Income tax provision(15)— — — — — — 124 110 
NET INCOME FROM CONTINUING OPERATIONS$173 $348 $33 $14 $333 $32 $20 $(124)$827 
DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS$0.51 $1.18 $0.11 $0.05 $1.13 $0.11 $0.07 $(0.42)$2.74 

Page 5

BECTON DICKINSON AND COMPANY
SUPPLEMENTAL INFORMATION
RECONCILIATION OF REPORTED RESULTS TO ADJUSTED RESULTS
(Unaudited; Amounts in millions, except per share data)
Three Months Ended June 30, 2021
Reported (GAAP)Purchase accounting adjustments (A)Integration costs (B)Restructuring costs (B)Transaction gain/loss, product and other litigation-related matters (C)European regulatory initiative-related costs (D)Income tax benefit of special itemsAdjusted
(Non-GAAP)
See Footnotes on Page 10
REVENUES$4,607 $— $— $— $— $— $— $4,607 
Gross margin1,958 349 — — — 10 — 2,317 
Selling and administrative expense1,200 (6)— — — — — 1,194 
Research and development expense330 (1)— — — (22)— 306 
OPERATING INCOME492 357 27 (4)(88)32 — 817 
Net interest expense(113)(1)— — — — — (115)
Other (expense) income, net(1)— — — 18 — — 17 
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES378 355 27 (4)(70)32 — 719 
Income tax (benefit) provision(28)— — — — — 59 31 
NET INCOME FROM CONTINUING OPERATIONS$407 $355 $27 $(4)$(70)$32 $(59)$688 
DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS$1.32 $1.22 $0.09 $(0.01)$(0.24)$0.11 $(0.20)$2.28 

Page 6

BECTON DICKINSON AND COMPANY
SUPPLEMENTAL INFORMATION
RECONCILIATION OF REPORTED RESULTS TO ADJUSTED RESULTS
(Unaudited; Amounts in millions, except per share data)
Three Months Ended September 30, 2021
Reported (GAAP)Purchase accounting adjustments (A)Integration costs (B)Restructuring costs (B)Transaction gain/loss, product and other litigation-related matters (C)European regulatory initiative-related costs (D)Investment gains/losses and asset impairments (E)Impacts of debt extinguishment (F)Income tax benefit of special itemsAdjusted
(Non-GAAP)
See Footnotes on Page 10
REVENUES$4,849 $— $— $— $— $— $— $— $— $4,849 
Gross margin2,086 354 — — 18 12 — — — 2,470 
Selling and administrative expense1,285 (1)— — — — — — — 1,283 
Research and development expense368 — — — — (31)— — — 337 
OPERATING INCOME380 356 41 17 13 43 — — — 850 
Net interest expense(109)(1)— — — — — 2 — (109)
Other (expense) income, net(120)(5)— — — — (46)153 — (18)
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES151 350 41 17 13 43 (46)154 — 724 
Income tax provision(4)— — — — — — — 85 82 
NET INCOME FROM CONTINUING OPERATIONS$154 $350 $41 $17 $13 $43 $(46)$154 $(85)$642 
DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS$0.46 $1.21 $0.14 $0.06 $0.05 $0.15 $(0.16)$0.53 $(0.30)$2.15 

Page 7

BECTON DICKINSON AND COMPANY
SUPPLEMENTAL INFORMATION
RECONCILIATION OF REPORTED RESULTS TO ADJUSTED RESULTS
(Unaudited; Amounts in millions, except per share data)
Twelve Months Ended September 30, 2020
Reported (GAAP)Purchase accounting adjustments (A)Integration costs (B)Restructuring costs (B)Transaction gain/loss, product and other litigation-related matters (C)European regulatory initiative-related costs (D)Investment gains/losses and asset impairments (E)Impacts of debt extinguishment (F)Income tax benefit of special itemsAdjusted (Non-GAAP)
See Footnotes on Page 10
REVENUES$16,074 $— $— $— $— $— $— $— $— $16,074 
Gross margin6,798 1,377 — — 244 31 98 — — 8,548 
Selling and administrative expense4,185 2 — — — (1)— — — 4,186 
Research and development expense1,039 — — — — (74)— — — 965 
OPERATING INCOME912 1,361 214 84 622 105 98 — — 3,397 
Net interest expense(521)(5)— — — — — — — (527)
Other income (expense), net23 — — — 9 — 1 8 — 41 
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES414 1,355 214 84 631 105 100 8 — 2,911 
Income tax provision62 — — — — — — — 392 454 
NET INCOME FROM CONTINUING OPERATIONS$352 $1,355 $214 $84 $631 $105 $100 $8 $(392)$2,457 
DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS$0.87 $4.80 $0.76 $0.30 $2.24 $0.37 $0.35 $0.03 $(1.39)$8.32 

Page 8

BECTON DICKINSON AND COMPANY
SUPPLEMENTAL INFORMATION
RECONCILIATION OF REPORTED RESULTS TO ADJUSTED RESULTS
(Unaudited; Amounts in millions, except per share data)
Twelve Months Ended September 30, 2019
Reported (GAAP)Purchase accounting adjustments (A)Integration costs (B)Restructuring costs (B)Transaction gain/loss, product and other litigation-related matters (C)European regulatory initiative-related costs (D)Investment gains/losses and asset impairments (E)Impacts of debt extinguishment (F)Hurricane-related insurance proceeds (G)Income tax benefit of special itemsAdjusted (Non-GAAP)
See Footnotes on Page 10
REVENUES$16,218 $— $— $— $— $— $— $— $— $— $16,218 
Gross margin7,498 1,374 25 — — 15 — — — — 8,912 
Selling and administrative expense4,185 (8)— — 11 (4)— — — — 4,184 
Research and development expense1,004 — — — — (32)(30)— — — 942 
OPERATING INCOME1,175 1,382 323 180 643 50 30 — — — 3,785 
Net interest expense(627)(5)— — — — — (5)— — (637)
Other income (expense), net43 122 — — 3 — (13)59 (24)— 190 
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES591 1,499 323 180 646 50 17 54 (24)— 3,339 
Income tax provision(141)— — — — — — — — 622 481 
NET INCOME FROM CONTINUING OPERATIONS$733 $1,499 $323 $180 $646 $50 $17 $54 $(24)$(622)$2,858 
DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS$2.11 $5.45 $1.18 $0.66 $2.35 $0.18 $0.06 $0.20 $(0.09)$(2.26)$9.85 


Page 9


The reconciliations of reported results to adjusted results on the previous pages reflect the following adjustments that are considered by management to be outside of BD’s underlying operational results or that affect period to period comparability:
(A)Purchase accounting adjustments-Includes amortization and other adjustments related to the purchase accounting for acquisitions impacting identified intangible assets and the valuation of fixed assets and debt. BD’s amortization expense is primarily recorded in Cost of products sold.
(B)Integration and restructuring costs-Includes amounts associated with integration and restructuring activities resulting from acquisitions, as well as simplification and other cost saving initiatives. These costs are recorded to Acquisitions and other restructurings.
(C)Transaction gain/loss, product and other litigation-related matters-Includes charges to record product liability reserves, including related legal defense costs, of $361 million, $378 million, and $914 million which were recorded to Other operating (income) expense, net in 2021, 2020 and 2019, respectively, as well as Alaris pump-related remediation costs of $56 million and $244 million recorded to Cost of Products Sold in 2021 and 2020, respectively. Other amounts, which were recorded to Other operating (income) expense, net, include gains of $158 million recognized on sale-leaseback transactions in 2021, a $336 million gain recognized on the sale of a business in 2019 and a $75 million charge to record the estimated cost of a product recall in the Medical segment in 2019.
(D)European regulatory initiative-related costs-Represents costs incurred to develop processes and systems to establish initial compliance with the European Union Medical Device Regulation and the European Union In Vitro Diagnostic Medical Device Regulation, which represent a significant, unusual change to the existing regulatory framework. We consider these costs to be duplicative of previously incurred costs and/or one-off costs, which are limited to a specific period of time. These expenses, which are recorded in Cost of products sold and Research and development expense, include the cost of labor, other services and consulting (in particular, research and development and clinical trials) and supplies, travel and other miscellaneous costs.
(E)Investment gains/losses and asset impairments-Includes investment gains/losses recorded to Other income (expense), net, as well as asset impairment charges.
(F)Impacts of debt extinguishment-Represents the impacts, which are recorded in Other income (expense), net and Interest expense, of our extinguishment of certain long-term senior notes.
(G)Hurricane-related insurance proceeds-Represents insurance proceeds relating to hurricane-related claims. These proceeds were recorded within Other income (expense), net.
(H)Dilutive impact-Represents the impact of transactions which affect the comparability of period-over-period calculations of diluted earnings per share.
Page 10